Study: Life Sciences Companies Concerned With Qui Tams
December 18, 2014 | Posted By: Hoyer Law Group, PLLC
A recent study of “life sciences companies” (i.e. biotechnology, medical device, and healthcare companies) revealed that False Claims Act qui tam liability is a primary issue discussed in general counsels’ offices. The study was sponsored by Foley Hoag and conducted by ALM Legal Intelligence. According to Kevin Iredell, vice president of ALM Legal Intelligence, “[t]he […]
Learn More